Chemical and Pharmaceutical Bulletin p. 501 - 510 (1999)
Update date:2022-08-03
Topics:
Ohkawa, Takehiko
Zenkoh, Tatsuya
Tomita, Masayuki
Hosogai, Naomi
Hemmi, Keiji
Tanaka, Hirokazu
Setoi, Hiroyuki
The present study was undertaken to evaluate whether a novel series of 2,6-diaza-5-oxobicyclo[5.4.0]undeca-1(7),8,10-triene derivatives exhibited antagonistic activity for vasopressin V1 and V2 receptors. Most of these compounds were
View MoreTaizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Contact:+1-416-493-6870
Address:Toronto, Canada
SHANGHAI ARCADIA BIOTECHNOLOGY LTD.
Contact:+86-21-61353236
Address:SUITE 901, BUILDING WENSLI, 1378 LU JIA BANG RD, SHANGAHI 200011, P.R.CHINA
website:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
HEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Doi:10.1016/0957-4166(95)00135-C
(1995)Doi:10.1021/ja01637a047
(1954)Doi:10.1021/ic00126a016
()Doi:10.1016/j.tetlet.2005.11.003
(2006)Doi:10.1246/cl.1995.459
(1995)Doi:10.1021/jo00120a036
(1995)